Welcome to the Apogee Therapeutics 2026 annual meeting of Shareholders. My name is Mark McKenna, chairman of Apogee's board of directors in today's meeting. Thank you all for joining us today. Let me begin by introducing your board of directors. Dr. Michael Henderson, our Chief Executive Officer, Dr. Lisa Bollinger, Jennifer Fox, William Jones Jr., Tomáš Kiselák, and Nimish Shah. I would also like to introduce other members of the management team who are joining us today. Jane Henderson, Chief Financial Officer, Dr. Carl Dambkowski, Chief Medical Officer, Matt Batters, Chief Legal Officer and Corporate Secretary. Representatives of our independent registered public accounting firm, Ernst & Young, are also joining us today. Matt Batters will serve as secretary of the meeting. A representative of the Creator Group has been appointed inspector of elections to examine and count proxies and votes for this meeting.
This meeting will be conducted in accordance with the meeting and rules of conduct that have been provided on the virtual meeting website. To maintain an informative, orderly, and constructive meeting, we ask that all participants abide by these rules. First, we will address the business items before shareholders, as set forth in the proxy statement. Following the discussion and vote on the business items, we'll conclude the business portion of the meeting. I will then answer any shareholder questions of general interest before adjourning. You may vote your shares online at any time prior to this meeting. Polls will be open at the beginning of the meeting and will be closed immediately after the presentation and discussion of today's proposals. The company's agents have certified that the proxy materials were made available to shareholders of record beginning April 24th.
We'll file copies of notice and related affidavit of mailing minutes of this meeting. I've received a note signed by the Inspector of Elections stating that it will faithfully execute, with strict impartiality, their duties, which will be filed with the minutes of this meeting. Our board set April 15th as the record date for this meeting. Only shareholders of record on that date are entitled to vote at this meeting. As of that date, there were 61,853,254 shares of the company's common voting issued and outstanding, each entitled to one vote. I've been informed by the Inspector of Elections that at least a majority of those shares are represented either virtually or by proxy for this meeting. Therefore, we have quorum. Accordingly, I declare that this meeting is properly constituted and convened.
The first matter to be considered is the election of the following Class III director nominees to the board to serve until the 2029 annual meeting of shareholders, Mark McKenna, Jennifer Fox, and William Jones Jr. The second matter to be considered is the ratification of the appointment of Ernst & Young as the company's independent auditor. The third matter to be considered is the approval on a non-binding advisory basis of the compensation of our named executive officers as disclosed in the proxy statement. We'll now see if there are any questions or comments regarding these proposals. I see no questions on the proposals. We will close the polls shortly. If you have previously voted, it is not necessary for you to vote today unless you wish to change your vote or requested a legal proxy.
Any shareholder who has not yet voted, wishes to change their vote, may do so now by clicking on the voting button on the web portal and following the instructions there. Since everyone has had an opportunity to vote, I now declare the polls are closed. According to the preliminary results, we've received votes and proxies sufficient to elect each of the director nominees and approve the other proposals voted on today. The final vote totals, including the vote validity received at this meeting, will be tabulated and filed with the SEC. This concludes the business portion of the meeting. We'll now be available for a few minutes for any questions or comments of the general interest you may have. Please note we'll attempt to answer all questions at this time, as long as they comply with the rules of conduct. I see no questions.
Thank you for attending today's meeting. This meeting is adjourned.
This now concludes the meeting. Thank you for joining.